You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IDXX Exercise Disclosure
Mazelsky Jonathan Jay · SEC Form 4 · Filed Nov 5, 2026
Exercise
Reported value range
Not reported
Mazelsky Jonathan Jay Executive Chair Of The Board
IDXX
Transaction date
Nov 4, 2026
Public filing date
Nov 5, 2026
Filing lag
Filed 1 day later
IDXX daily price context
Close on/before transaction
$698.55
Nov 4, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right-to-buy) on Common Stock
- Quantity / price
- 25,140 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000874716-26-000144
Filing cohort
Transactions in this filing
Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$22.16M
Buys / sales
0 / 13
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $1.3M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $593.88K |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $235.65K |
| Idexx Laboratories Inc /de IDXX | Exercise | Nov 4, 2026 | $4.48M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $1.5M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $551.26K |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $1.17M |
| Idexx Laboratories Inc /de IDXX Current | Exercise | Nov 4, 2026 | Not reported |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $1.36M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $3.18M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $2.85M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $2.78M |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $169.34K |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $921.7K |
| Idexx Laboratories Inc /de IDXX | Sale | Nov 4, 2026 | $1.07M |